Global Botulinum Toxin Market: Size, Trends and Forecasts (2016-2020)
Scope of the Report
The report titled “Global Botulinum Toxin Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global botulinum toxin market with detailed analysis of the actual and the expected market size along with the market size of each market segment on the basis of indication as well as products.
The report provides detailed regional analysis of the U.S., European Union, Japan and Korea for the botulinum toxin market. Regional analysis includes market share of each region or country and the actual and forecasted market size of the botulinum toxin market along with the market segments of the aforementioned regions.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global botulinum toxin market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global botulinum toxin market is stiff and dominated by the big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.
Revance Therapeutics, Inc.
Botulinum toxin is produced by clostridium botulinum, a gram-positive anaerobic bacterium. It is broken into seven neurotoxins. Currently, it is used in almost every sub-specialty of medicine and for cosmetic purpose for temporarily reducing glabeller forehead frown lines. The various botulinum toxins possess individual potencies, and care is required to assure proper use and avoid medication errors.
The global botulinum toxin market has increased at a significant annual growth rate in 2015 as compared to the preceding year 2014 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The upsurge in the market was due to various factors such as increased patient comfort, shorter procedure times and immediate results. The market can be segmented on the basis of indications as therapeutics and aesthetics, of which therapeutics govern the market.
The major growth drivers for the botulinum toxin market are: upsurge in the facial aesthetics market, reduction in prices of botulinum toxin treatment and social awareness among people. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as side-effects of consuming botulinum toxin and bioterrorism.